Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Stem Cell Research & Therapy
  4. Volume 20, Issue 3
  5. Article
Volume 20, Issue 3
  • ISSN: 1574-888X
  • E-ISSN: 2212-3946
file format text download EPUB
file format pdf download PDF
side by side viewer icon HTML

Abstract

Introduction

At present, cyclosporine (CsA) is the first-line treatment for Pure Red Cell Aplasia (PRCA), but CsA administration can be associated with a number of side effects due to its high toxicity. Therefore, it is urgent to explore a safe and effective treatment for elderly patients who cannot be treated with conventional doses of CsA, especially those with multiple complications. Allogeneic Stem Cell Transplantation (ASCT) for PRCA is a promising treatment, but reports of using umbilical cord blood (UCB) are very rare.

Case Presentation

In this report, UCB and umbilical cord mesenchymal stem cells (UC-MSCs) combined with low-dose CsA (1-3mg/kg/d) were used to treat 3 elderly patients who were diagnosed with PRCA combined with multiple complications in heart, lung, and renal. The treatments were successful without complications, and 12 months after stem cell infusion, the blood tests of the patients came normal. Moreover, the function of the liver, heart, and kidney continued to be stable.

Conclusion

This report provides an effective regimen of using UCB and UC-MSCs combined with low-dose CsA (1-3 mg/kg/d) to treat PRCA, especially for elderly patients with multiple complications who cannot use the conventional dosage.

© 2025 Bentham Science Publishers
© 2025 The Author(s). Published by Bentham Science Publishers. This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/cscr/10.2174/011574888X290378240424075002
2024-05-02
2025-05-03

  • From This Site

    /content/journals/cscr/10.2174/011574888X290378240424075002
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
The full text of this item is not currently available.

References

  1. ManglaA. HamadH. Pure Red Cell Aplasia.Treasure Island (FL): StatPearls2023
     [Google Scholar]
  2. ViveroA. PeedinA.R. GaoY. KarpJ.K. Successful treatment of pure red cell aplasia using therapeutic plasma exchange after ABO ‐incompatible hematopoietic stem cell transplant.J. Clin. Apher.202338449549910.1002/jca.22041 36703597
     [Google Scholar]
  3. MeansR.T.Jr Pure red cell aplasia.Blood2016128212504250910.1182/blood‑2016‑05‑717140 27881371
     [Google Scholar]
  4. HirokawaM. SawadaK. FujishimaN. Long‐term outcome of patients with acquired chronic pure red cell aplasia (PRCA) following immunosuppressive therapy: A final report of the nationwide cohort study in 2004/2006 by the Japan PRCA collaborative study group.Br. J. Haematol.2015169687988610.1111/bjh.13376 25807974
     [Google Scholar]
  5. HalkesC. de WreedeL.C. KnolC. Allogeneic stem cell transplantation for acquired pure red cell aplasia.Am. J. Hematol.20199411E294E29610.1002/ajh.25609 31396977
     [Google Scholar]
  6. LongvalT. GalimardJ.E. LeprêtreA.C. Treatment for pure red cell aplasia after major ABO‐incompatible allogeneic stem cell transplantation: A multicentre study.Br. J. Haematol.2021193481482610.1111/bjh.17463 33844842
     [Google Scholar]
  7. TsengS.B. LinS.F. ChangC.S. Successful treatment of acquired pure red cell aplasia (PRCA) by allogeneic peripheral blood stem cell transplantation.Am. J. Hematol.200374427327510.1002/ajh.10421 14635209
     [Google Scholar]
  8. InoueN.T. NagamuraF. Umbilical cord blood and cord tissue banking as somatic stem cell resources to support medical cell modalities.Inflamm. Regen.20234315910.1186/s41232‑023‑00311‑4 38053217
     [Google Scholar]
  9. WangJ. MethenyL. Umbilical cord blood derived cellular therapy: Advances in clinical development.Front. Oncol.202313116726610.3389/fonc.2023.1167266 37274288
     [Google Scholar]
  10. MebarkiM. IglickiN. MarignyC. Development of a human umbilical cord-derived mesenchymal stromal cell-based advanced therapy medicinal product to treat immune and/or inflammatory diseases.Stem Cell Res. Ther.202112157110.1186/s13287‑021‑02637‑7 34774107
     [Google Scholar]
  11. NiuH. YanL. YangL. High TOX expression on CD8+ T cells in pure red cell aplasia.Ann. Hematol.202310251247125510.1007/s00277‑023‑05174‑w 36933041
     [Google Scholar]
  12. MeansR.T.Jr Pure red cell aplasia: The second hundred years.Am. J. Med. Sci.2023366316016610.1016/j.amjms.2023.06.009 37327996
     [Google Scholar]
  13. KawakamiF. KawakamiT. YamaneT. T cell clonal expansion and STAT3 mutations: A characteristic feature of acquired chronic T cell-mediated pure red cell aplasia.Int. J. Hematol.2022115681682510.1007/s12185‑022‑03310‑2 35275353
     [Google Scholar]
  14. LongZ. LiH. DuY. ChenM. ZhuangJ. HanB. Gene mutation profile in patients with acquired pure red cell aplasia.Ann. Hematol.20209981749175410.1007/s00277‑020‑04154‑8 32594217
     [Google Scholar]
  15. LiuM. LiuT. MengW.T. ZhuH.L. CuiX. Role of gammadeltaT cells in pathogenesis of acquired pure red cell aplastic anemia.J Exper Hematol2007151142146 17490541
     [Google Scholar]
  16. GurnariC. MaciejewskiJ.P. How I manage acquired pure red cell aplasia in adults.Blood2021137152001200910.1182/blood.2021010898 33657207
     [Google Scholar]
  17. PatockaJ. NepovimovaE. KucaK. WuW. CyclosporineA. Chemistry and toxicity - A review.Curr. Med. Chem.202128203925393410.2174/1875533XMTEwpNDktz 33023428
     [Google Scholar]
  18. KasturiS. SammaritanoL.R. Corticosteroids in lupus.Rheum. Dis. Clin. North Am.20164214762[viii.10.1016/j.rdc.2015.08.00726611550
     [Google Scholar]
  19. TelesK.A. Medeiros-SouzaP. LimaF.A.C. AraújoB.G. LimaR.A.C. Cyclophosphamide administration routine in autoimmune rheumatic diseases: A review.Rev. Bras. Reumatol. Engl. Ed.201757659660410.1016/j.rbre.2016.09.008 29173694
     [Google Scholar]
  20. ChakrabartyP. RudraS. Autologus or allogenic uses of umbilical cord blood whole or RBC transfusion - A review.Mymensingh Med. J.2013221210217 23416835
     [Google Scholar]
  21. OrlandoN. PellegrinoC. ValentiniC.G. Umbilical cord blood: Current uses for transfusion and regenerative medicine.Transfus. Apheresis Sci.202059510295210.1016/j.transci.2020.102952 32972860
     [Google Scholar]
  22. ShiP.A. LuchsingerL.L. GreallyJ.M. DelaneyC.S. Umbilical cord blood: An undervalued and underutilized resource in allogeneic hematopoietic stem cell transplant and novel cell therapy applications.Curr. Opin. Hematol.202229631732610.1097/MOH.0000000000000732 36066376
     [Google Scholar]
  23. TeofiliL. PapacciP. GiannantonioC. BianchiM. ValentiniG.C. VentoG. Allogenic cord blood transfusion in preterm infants.Clin. Perinatol.202350488189310.1016/j.clp.2023.07.005 37866854
     [Google Scholar]
  24. BhattacharyaN. Placental umbilical cord whole blood transfusion to combat anemia in the background of advanced rheumatoid arthritis and emaciation and its potential role as immunoadjuvant therapy.Clin. Exp. Obstet. Gynecol.20063312833 16761535
     [Google Scholar]
  25. HuQ.L. HanB. HeW.H. YangC. ChenM. Allogeneic unrelated non HLA matched umbilical cord blood transfusion for refractory immune cytopenia: Results of a phase I clinical trial.Chin J Hematol2023445431435 37550196
     [Google Scholar]
  26. LaskowitzD.T. BennettE.R. DurhamR.J. Allogeneic umbilical cord blood infusion for adults with ischemic stroke: Clinical outcomes from a phase I safety study.Stem Cells Transl. Med.20187752152910.1002/sctm.18‑0008 29752869
     [Google Scholar]
  27. DawsonG. SunJ.M. BakerJ. A phase II randomized clinical trial of the safety and efficacy of intravenous umbilical cord blood infusion for treatment of children with autism spectrum disorder.J. Pediatr.2020222164173.e510.1016/j.jpeds.2020.03.011 32444220
     [Google Scholar]
  28. VettenrantaK. SaarinenU.M. Cord blood stem cell transplantation for Diamond–Blackfan anemia.Bone Marrow Transplant.199719550750810.1038/sj.bmt.1700675 9052920
     [Google Scholar]
  29. BonnoM. AzumaE. NakanoT. Successful hematopoietic reconstitution by transplantation of umbilical cord blood cells in a transfusion-dependent child with Diamond–Blackfan anemia.Bone Marrow Transplant.1997191838510.1038/sj.bmt.1700607 9012937
     [Google Scholar]
  30. XieL. FangY. YuZ. Increased immunosuppressive treatment combined with unrelated umbilical cord blood infusion in children with severe aplastic anemia.Cell. Immunol.20142891-215015410.1016/j.cellimm.2014.03.014 24838091
     [Google Scholar]
  31. ZhouF. ZhangF. ZhangL. A multicentre trial of intensive immunosuppressive therapy combined with umbilical cord blood for the treatment of severe aplastic anaemia.Ann. Hematol.202210181785179410.1007/s00277‑022‑04864‑1 35661248
     [Google Scholar]
  32. JiangJ. CaiY. WanL. YangJ. WangC. Cord blood infusion-accelerated hematopoietic recovery after combined immunosuppressive therapy with fludarabine and rabbit ATG in severe aplastic anemia.Int. J. Hematol.2020111336036810.1007/s12185‑019‑02807‑7 31900878
     [Google Scholar]
  33. LotfyA. AboQuellaN.M. WangH. Mesenchymal stromal/stem cell (MSC)-derived exosomes in clinical trials.Stem Cell Res. Ther.20231416610.1186/s13287‑023‑03287‑7 37024925
     [Google Scholar]
  34. ZhaoK. LiuQ. The clinical application of mesenchymal stromal cells in hematopoietic stem cell transplantation.J. Hematol. Oncol.2016914610.1186/s13045‑016‑0276‑z 27193054
     [Google Scholar]
  35. ChungJ.W. ChangW.H. BangO.Y. Efficacy and safety of intravenous mesenchymal stem cells for ischemic stroke.Neurology2021967e1012e102310.1212/WNL.0000000000011440 33472925
     [Google Scholar]
  36. LanzoniG. LinetskyE. CorreaD. Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial.Stem Cells Transl. Med.202110566067310.1002/sctm.20‑0472 33400390
     [Google Scholar]
  37. ChuM. WangH. BianL. Nebulization therapy with umbilical cord mesenchymal stem cell-derived exosomes for COVID-19 pneumonia.Stem Cell Rev. Rep.20221862152216310.1007/s12015‑022‑10398‑w 35665467
     [Google Scholar]
  38. LeeW.S. KimH.J. KimK.I. KimG.B. JinW. Intra-articular injection of autologous adipose tissue-derived mesenchymal stem cells for the treatment of knee osteoarthritis: A phase IIb, randomized, placebo-controlled clinical trial.Stem Cells Transl. Med.20198650451110.1002/sctm.18‑0122 30835956
     [Google Scholar]
  39. IzadiM. NejadS.H.A. MoazenchiM. Mesenchymal stem cell transplantation in newly diagnosed type-1 diabetes patients: A phase I/II randomized placebo-controlled clinical trial.Stem Cell Res. Ther.202213126410.1186/s13287‑022‑02941‑w 35725652
     [Google Scholar]
  40. KimH.J. ChoK.R. JangH. Intracerebroventricular injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer’s disease dementia: A phase I clinical trial.Alzheimers Res. Ther.202113115410.1186/s13195‑021‑00897‑2 34521461
     [Google Scholar]
  41. NautaA.J. FibbeW.E. Immunomodulatory properties of mesenchymal stromal cells.Blood2007110103499350610.1182/blood‑2007‑02‑069716 17664353
     [Google Scholar]
  42. ShenZ. HuangW. LiuJ. TianJ. WangS. RuiK. Effects of mesenchymal stem cell-derived exosomes on autoimmune diseases.Front. Immunol.20211274919210.3389/fimmu.2021.749192 34646275
     [Google Scholar]
  43. SengunE. WolfsT.G.A.M. van BruggenV.L.E. Umbilical cord-mesenchymal stem cells induce a memory phenotype in CD4+ T cells.Front. Immunol.202314112835910.3389/fimmu.2023.1128359 37409122
     [Google Scholar]
  44. BarreraC.M. ZapataF.N. DiazL.N. Integrated analysis of transcriptome and secretome from umbilical cord mesenchymal stromal cells reveal new mechanisms for the modulation of inflammation and immune activation.Front. Immunol.20201157548810.3389/fimmu.2020.575488 33117373
     [Google Scholar]
  45. WeiX. ChengX. LuoY. LiX. Umbilical cord-derived mesenchymal stem cells attenuate S100-induced autoimmune hepatitis via modulating Th1 and Th17 cell responses in mice.Stem Cells Int.2023202311910.1155/2023/9992207 37881518
     [Google Scholar]
  46. YangH. SunJ. WangF. LiY. BiJ. QuT. Umbilical cord-derived mesenchymal stem cells reversed the suppressive deficiency of T regulatory cells from peripheral blood of patients with multiple sclerosis in a co-culture - A preliminary study.Oncotarget2016745725377254510.18632/oncotarget.12345 27705922
     [Google Scholar]
  47. YinY. HaoH. ChengY. The homing of human umbilical cord-derived mesenchymal stem cells and the subsequent modulation of macrophage polarization in type 2 diabetic mice.Int. Immunopharmacol.20186023524510.1016/j.intimp.2018.04.051 29778021
     [Google Scholar]
  48. WuR. FanX. WangY. Mesenchymal stem cell-derived extracellular vesicles in liver immunity and therapy.Front. Immunol.20221383387810.3389/fimmu.2022.833878 35309311
     [Google Scholar]
  49. ZhangZ. HuangS. WuS. Clearance of apoptotic cells by mesenchymal stem cells contributes to immunosuppression via PGE2.EBioMedicine20194534135010.1016/j.ebiom.2019.06.016 31248835
     [Google Scholar]
  50. SergeevichevaV. KruchkovaI. ChernykhE. Rapid recovery from chronic PRCA by MSC infusion in patient after major ABO-mismatched alloSCT.Case Rep. Med.201220121410.1155/2012/862721 22778753
     [Google Scholar]
  51. VlachosA. MuirE. How I treat diamond-blackfan anemia.Blood2010116193715372310.1182/blood‑2010‑02‑251090 20651069
     [Google Scholar]
/content/journals/cscr/10.2174/011574888X290378240424075002
Loading
Umbilical Cord Blood and UC-MSCs Combined with Low-Dose Immunosuppressant in the Treatment of Elderly Patients with Pure Red Cell Aplastic: A Case Series
Curr Stem Cell Res Ther 20, 350 (2025); https://doi.org/10.2174/011574888X290378240424075002
/content/journals/cscr/10.2174/011574888X290378240424075002
/content/journals/cscr/10.2174/011574888X290378240424075002
Loading

Data & Media loading...


  • Article Type:     Case Report
Keyword(s): cord blood; cyclosporine A; elderly patients; immunotherapy; mesenchymal stem cells; Pure red cell aplasia

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test